TrialOncotarget2014

Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive B-cell non-hodgkin lymphoma.

Qingqing Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.